- Home
- AVNT vs IMVT Comparison
AVNT vs IMVT Comparison
Compare AVNT & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNT
- IMVT
- Stock Information
- Founded
- AVNT 1927
- IMVT 2018
- Country
- AVNT United States
- IMVT United States
- Employees
- AVNT N/A
- IMVT N/A
- Industry
- AVNT Major Chemicals
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVNT Industrials
- IMVT Health Care
- Exchange
- AVNT Nasdaq
- IMVT Nasdaq
- Market Cap
- AVNT 3.4B
- IMVT 2.7B
- IPO Year
- AVNT 1993
- IMVT N/A
- Fundamental
- Price
- AVNT $32.48
- IMVT $17.91
- Analyst Decision
- AVNT Strong Buy
- IMVT Buy
- Analyst Count
- AVNT 5
- IMVT 10
- Target Price
- AVNT $49.40
- IMVT $40.14
- AVG Volume (30 Days)
- AVNT 842.8K
- IMVT 1.2M
- Earning Date
- AVNT 08-01-2025
- IMVT 08-05-2025
- Dividend Yield
- AVNT 3.26%
- IMVT N/A
- EPS Growth
- AVNT N/A
- IMVT N/A
- EPS
- AVNT 1.08
- IMVT N/A
- Revenue
- AVNT $3,238,000,000.00
- IMVT N/A
- Revenue This Year
- AVNT $2.77
- IMVT N/A
- Revenue Next Year
- AVNT $4.20
- IMVT N/A
- P/E Ratio
- AVNT $30.61
- IMVT N/A
- Revenue Growth
- AVNT 3.58
- IMVT N/A
- 52 Week Low
- AVNT $27.86
- IMVT $12.72
- 52 Week High
- AVNT $54.68
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- AVNT 42.32
- IMVT 59.73
- Support Level
- AVNT $32.34
- IMVT $17.39
- Resistance Level
- AVNT $33.63
- IMVT $19.06
- Average True Range (ATR)
- AVNT 0.94
- IMVT 0.76
- MACD
- AVNT -0.00
- IMVT 0.09
- Stochastic Oscillator
- AVNT 29.12
- IMVT 64.72
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.